Credit: Getty Images. Results are from a meta-analysis of 33 trials involving 35,939 patients with overactive bladder. Overactive bladder treatment using antimuscarinic drugs increases the risks for ...

Objective: To review the efficacy and safety of fesoterodine, a new antimuscarinic for treating overactive bladder (OAB) symptoms. Methods: Review of efficacy and safety data from the pivotal phase 3 ...

*Predominant types of OAB were defined as follows: urgency incontinence = urge incontinence only; mixed = mixed stress/urge incontinence with urge as a predominant factor; frequency = ...

Objective: Describe challenges to improving management of overactive bladder (OAB) outcomes and summarize research findings on critical success factors for supporting OAB treatment. A ...

The AUA/SUFU guideline recommends first-, second-, and third-line treatment for OAB. First-line treatment includes behavioral therapies that may be combined with antimuscarinics. Second-line ...

BARCELONA—Sacral neuromodulation (SNM) with Interstim Therapy is significantly better than an additional trial of standard medical treatment (SMT) for patients with refractory overactive bladder (OAB) ...

Urge urinary incontinence (UUI) is a symptom of overactive bladder. Antimuscarinic agents are the first-line therapy for patients with overactive bladder, and the continence rate (the percentage of ...

A new expert guideline on idiopathic overactive bladder (OAB) provides clinicians with 33 evidence-based practice pointers about evaluation, diagnosis, and treatment of the condition. 1 Key among them ...

A study from the University of Houston College of Pharmacy, and published in the Journal of the American Geriatrics Society, has evaluated the risk of overactive bladder (OAB) as a side effect of ...

Insufficient effect and poor tolerability 26 (10.9) 28 (11.7) 31 (13.1) 25 (10.8) *Predominant types of OAB were defined as follows: urgency incontinence = urge incontinence only; mixed = mixed stress ...